Article thumbnail

CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells

By S Amatschek, R Lucas, A Eger, M Pflueger, H Hundsberger, C Knoll, S Grosse-Kracht, W Schuett, F Koszik, D Maurer and C Wiesner
Topics: Molecular Diagnostics
Publisher: Nature Publishing Group
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2008). Breakdown of the endothelial barrier function in tumor cell transmigration.
  2. (1998). Chemokines and their role in tumor growth and metastasis. J Immunol Methods 220: 1–17
  3. (1997). Chemokines. Blood 90: 909–928 Romagnani
  4. (1998). Contribution of the CXC chemokines IP-10 and Mig to the antitumor effects of IL-12.
  5. (2005). Evidence for a blood-brain barrier defect.
  6. (2007). Med 184: 963–969 Mehrad
  7. (2000). Openings between defective endothelial cells explain tumor vessel leakiness.
  8. (1990). Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells. J Cell Biol 110: 1427–1438 Balkwill F, Mantovani A
  9. (2000). The hallmarks of cancer.